Acne Vulgaris

NEW ORLEANS — Clinicians should be mindful of pigmentary concerns and colorism in their patients with skin of color and recognize the motivations behind skin lightening desires, according to a study presented here.

MIAMI BEACH, Fla. — Clascoterone cream 1% demonstrated long-term efficacy and a favorable safety profile in patients aged older than 12 years with acne vulgaris, according to extension study results presented here.

This year, presentations and perspectives from dermatology’s biggest annual conferences comprise the majority of Healio’s most read acne articles of 2022.

Tret-BPO cream may improve adherence and lesions in the treatment of acne vulgaris, according to a literature review.

DENVER — A 1,726 nm laser was safe and effective in treating moderate to severe acne vulgaris, according to a study presented here.

BOSTON — Treatment with clascoterone cream effectively treated facial acne vulgaris among patients aged 12 years and older, according to a poster presented at the American Academy of Dermatology Annual Meeting.

The FDA approved many new drugs and technologies over the past year, and in the dermatology world those approvals included treatments for a multitude of conditions.

Twyneo cream, a fixed-dose combination of tretinoin and benzoyl peroxide, has been approved by the FDA for the treatment of acne vulgaris, Sol-Gel Technologies announced in a press release.

Identifying the challenges of treating pediatric patients with skin of color will allow for better developed treatment plans, according to a presenter at the Masters of Pediatric Dermatology meeting.

Risk of inflammatory bowel disease was generally low among individuals with acne vulgaris treated with isotretinoin, according to a study.